Natco Pharma Limited
NATCOPHARM
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 2026597
Quarter ₹ crore YoY Jun 2024 1,237 +18.0% Sept 2024 1,293 +38.9% Dec 2024 408 -34.8% Mar 2025 1,157 +20.0% Jun 2025 1,193 -3.6% Sept 2025 1,264 -2.2% Dec 2025 529 +29.7% Mar 2026 609 -47.4% Jun 2026 597 -50.0% - ₹ crore
Jun 202648
Quarter ₹ crore Jun 2024 40 Sept 2024 51 Dec 2024 168 Mar 2025 62 Jun 2025 60 Sept 2025 93 Dec 2025 55 Mar 2026 73 Jun 2026 48 - ₹ crore
Jun 2026645
Quarter ₹ crore Jun 2024 1,277 Sept 2024 1,344 Dec 2024 576 Mar 2025 1,220 Jun 2025 1,252 Sept 2025 1,358 Dec 2025 584 Mar 2026 682 Jun 2026 645 - Cost structure
- ₹ crore
Jun 2026151
Quarter ₹ crore Jun 2024 120 Sept 2024 133 Dec 2024 124 Mar 2025 139 Jun 2025 144 Sept 2025 179 Dec 2025 137 Mar 2026 133 Jun 2026 151 - ₹ crore
Jun 2026543
Quarter ₹ crore Jun 2024 519 Sept 2024 547 Dec 2024 425 Mar 2025 699 Jun 2025 709 Sept 2025 772 Dec 2025 459 Mar 2026 572 Jun 2026 543 - Exceptional items and tax
- ₹ crore
Jun 2026102
Quarter ₹ crore Jun 2024 758 Sept 2024 797 Dec 2024 150 Mar 2025 521 Jun 2025 543 Sept 2025 586 Dec 2025 125 Mar 2026 110 Jun 2026 102 - ₹ crore
Jun 202627
Quarter ₹ crore Jun 2024 122 Sept 2024 136 Dec 2024 25 Mar 2025 93 Jun 2025 79 Sept 2025 85 Dec 2025 18 Mar 2026 -100 Jun 2026 27 - Profit
- ₹ crore
Jun 202675
Quarter ₹ crore YoY Jun 2024 636 +57.0% Sept 2024 661 +83.5% Dec 2024 125 -34.9% Mar 2025 428 +22.6% Jun 2025 464 -27.1% Sept 2025 501 -24.2% Dec 2025 107 -14.4% Mar 2026 210 -51.0% Jun 2026 75 -83.9% - Per share
- ₹ per share
Jun 20264.17
Quarter ₹ per share Jun 2024 35.53 Sept 2024 36.91 Dec 2024 6.97 Mar 2025 23.90 Jun 2025 25.91 Sept 2025 27.97 Dec 2025 5.97 Mar 2026 11.70 Jun 2026 4.17 - Leverage
Debt to equity
timesJun 20240.00x
Quarter times Jun 2024 0.00x Sept 2024 — Dec 2024 — Mar 2025 — Jun 2025 — Sept 2025 — Dec 2025 — Mar 2026 — Jun 2026 —
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 1,237 | 1,293 | 408 | 1,157 | 1,193 | 1,264 | 529 | 609 | 597 | |
| Revenue YoY | +18.0% | +38.9% | -34.8% | +20.0% | -3.6% | -2.2% | +29.7% | -47.4% | -50.0% |
| 40 | 51 | 168 | 62 | 60 | 93 | 55 | 73 | 48 | |
| 1,277 | 1,344 | 576 | 1,220 | 1,252 | 1,358 | 584 | 682 | 645 | |
| Cost structure | |||||||||
| 120 | 133 | 124 | 139 | 144 | 179 | 137 | 133 | 151 | |
| 519 | 547 | 425 | 699 | 709 | 772 | 459 | 572 | 543 | |
| Exceptional items and tax | |||||||||
| 758 | 797 | 150 | 521 | 543 | 586 | 125 | 110 | 102 | |
| 122 | 136 | 25 | 93 | 79 | 85 | 18 | -100 | 27 | |
| Profit | |||||||||
| 636 | 661 | 125 | 428 | 464 | 501 | 107 | 210 | 75 | |
| Net profit YoY | +57.0% | +83.5% | -34.9% | +22.6% | -27.1% | -24.2% | -14.4% | -51.0% | -83.9% |
| Per share | |||||||||
| 35.53 | 36.91 | 6.97 | 23.90 | 25.91 | 27.97 | 5.97 | 11.70 | 4.17 | |
| Leverage | |||||||||
| Debt to equity | 0.00x | — | — | — | — | — | — | — | — |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.